ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Orlando, FL, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Orlando, Florida, United States and 44 other locations

placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...

Enrolling
Diabetes, Type II
Obesity
Drug: AZD6234
Drug: Placebo to match

Phase 2

AstraZeneca
AstraZeneca

Winter Park, Florida, United States and 17 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Mount Dora, Florida, United States of America and 24 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Begins enrollment this month
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Winter Park, Florida, United States and 45 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Procedure: Sham Comparator
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Sanford, Florida, United States and 87 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Port Orange, Florida, United States of America and 78 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Winter Park, Florida, United States and 186 other locations

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors ...

Enrolling
Type 2 Diabetes
Cortisol Excess
Drug: clofutriben
Drug: Placebo

Phase 2

Sparrow Pharmaceuticals

Edgewater, Florida, United States and 41 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Orlando, Florida, United States and 39 other locations

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Enrolling
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Kissimmee, Florida, United States and 66 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems